NANOG is multiply phosphorylated and directly modified by ERK2 and CDK1 in vitro.

Stem Cell Reports

Stem Cells and Regenerative Medicine, Morgridge Institute for Research, Madison, WI 53715, USA ; Department of Cell & Regenerative Biology, University of Wisconsin-Madison, Madison, WI 53706, USA ; Department of Molecular, Cellular & Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA 93106, USA.

Published: January 2014

AI Article Synopsis

  • NANOG is a key protein that helps maintain the ability of stem cells to stay undifferentiated and self-renewing, but its regulation after being made (posttranslational regulation) isn't well understood.* -
  • Researchers found eleven phosphorylation sites on human NANOG, with nine of them affecting single amino acids, which can influence its function.* -
  • To uncover the kinases responsible for these modifications, they created a new assay called MAKS that can test multiple kinases at once, revealing that ERK2 and CDK1/CyclinA2 specifically phosphorylate NANOG.*

Article Abstract

NANOG is a divergent homeobox protein and a core component of the transcriptional circuitry that sustains pluripotency and self-renewal. Although NANOG has been extensively studied on the transcriptional level, little is known regarding its posttranslational regulation, likely due to its low abundance and challenging physical properties. Here, we identify eleven phosphorylation sites on endogenous human NANOG, nine of which mapped to single amino acids. To screen for the signaling molecules that impart these modifications, we developed the multiplexed assay for kinase specificity (MAKS). MAKS simultaneously tests activity for up to ten kinases while directly identifying the substrate and exact site of phosphorylation. Using MAKS, we discovered site-specific phosphorylation by ERK2 and CDK1/CyclinA2, providing a putative link between key signaling pathways and NANOG.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966117PMC
http://dx.doi.org/10.1016/j.stemcr.2013.12.005DOI Listing

Publication Analysis

Top Keywords

nanog
5
nanog multiply
4
multiply phosphorylated
4
phosphorylated directly
4
directly modified
4
modified erk2
4
erk2 cdk1
4
cdk1 vitro
4
vitro nanog
4
nanog divergent
4

Similar Publications

Polymorphisms in nanog are associated with oral leukoplakia: case-control study.

Odontology

December 2024

Pontifícia Universidade Católica Do Paraná. Imaculada Conceição, 1155, Prado Velho, Curitiba, PR, 80215-901, Brazil.

To investigate the association of NANOG polymorphisms with oral leukoplakia. In this case-control study, 68 cases of oral leukoplakia, and 21 of normal oral mucosa (control) were submitted to genotyping of tagSNPs polymorphisms: rs877716 and rs10845877 in NANOG, through real-time polymerase chain reaction (PCR). Pearson's chi-squared and Fisher's exact statistical tests were used, with a significance of 5%.

View Article and Find Full Text PDF

These protocols describe a detailed method to determine the DNA damage and F-actin and microtubule defects of metaphase II oocytes caused by hexavalent chromium, Cr(VI), an endocrine disrupting chemical (EDC). The protocol provides systematic steps to determine protein expression encoded by pluripotency proteins such as Oct4, Nanog, and Cdx2 during early embryonic development. Occupational or environmental exposure to EDCs has significantly increased infertility in both men and women.

View Article and Find Full Text PDF

Analysis of synthetic polymer hydrogel-based generation of leukemia stem cells.

Biochem Biophys Res Commun

December 2024

Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Japan; Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan; Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Japan. Electronic address:

Leukemia stem cells (LSCs), capable of simultaneous self-renewal and differentiation, are resistant to chemotherapy and the cause of relapse in refractory cases of leukemia. As a method to rapidly generate LSCs has not been established, research on LSCs as therapeutic targets has been hampered. Here, we demonstrate that K562 leukemia cells acquired LSC properties with increase in stemness markers such as CD34, Oct3/4, and Nanog and metabolic alterations towards OXPHOS by culturing cells on synthetic polymer hydrogels.

View Article and Find Full Text PDF

Alpha-lipoic acid targets expression to inhibit cervical cancer progression.

Acta Biochim Biophys Sin (Shanghai)

December 2024

Department of Histology and Embryology/Key Laboratory of Xinjiang Endemic and Ethnic Diseases of Ministry of Education, Shihezi University School of Medicine, Shihezi 832000, China.

It is unclear what part KLF7 plays in cervical cancer. In this study, immunohistochemical and bioinformatics analyses reveal that KLF7 expression is lower in normal cervical tissues than in cervical cancer tissues ( ≤0.05), and the high level of transcripts in cervical cancer tissues is negatively correlated with patients' overall and disease-free survival ( <0.

View Article and Find Full Text PDF

Background: Differentiation of patient-specific induced pluripotent stem cells (iPS) helps researchers to study the individual sensibility to drugs. However, differentiation protocols are time-consuming, and not all tissues have been studied. Few works are available regarding pancreatic exocrine differentiation of iPS cells, and little is known on culturing and cryopreserving these cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!